Non-alcoholic fatty liver disease: a multi-system disease influenced by ageing and sex, and affected by adipose tissue and intestinal function
- PMID: 35934688
- DOI: 10.1017/S0029665121003815
Non-alcoholic fatty liver disease: a multi-system disease influenced by ageing and sex, and affected by adipose tissue and intestinal function
Abstract
In recent years, a wealth of factors are associated with increased risk of developing non-alcoholic fatty liver disease (NAFLD) and NAFLD is now thought to increase the risk of multiple extra-hepatic diseases. The aim of this review is first to focus on the role of ageing and sex as key, poorly understood risk factors in the development and progression of NAFLD. Secondly, we aim to discuss the roles of white adipose tissue (WAT) and intestinal dysfunction, as producers of extra-hepatic factors known to further contribute to the pathogenesis of NAFLD. Finally, we aim to summarise the role of NAFLD as a multi-system disease affecting other organ systems beyond the liver. Both increased age and male sex increase the risk of NAFLD and this may be partly driven by alterations in the distribution and function of WAT. Similarly, changes in gut microbiota composition and intestinal function with ageing and chronic overnutrition are likely to contribute to the development of NAFLD both directly (i.e. by affecting hepatic function) and indirectly via exacerbating WAT dysfunction. Consequently, the presence of NAFLD significantly increases the risk of various extra-hepatic diseases including CVD, type 2 diabetes mellitus, chronic kidney disease and certain extra-hepatic cancers. Thus changes in WAT and intestinal function with ageing and chronic overnutrition contribute to the development of NAFLD - a multi-system disease that subsequently contributes to the development of other chronic cardiometabolic diseases.
Keywords: Adipose tissue dysfunction; Age; CVD; Diabetes; Gut microbiota; Non-alcoholic fatty liver disease; Sex.
Similar articles
-
Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease.Contemp Clin Trials. 2018 Aug;71:113-123. doi: 10.1016/j.cct.2018.05.010. Epub 2018 May 19. Contemp Clin Trials. 2018. PMID: 29787859 Clinical Trial.
-
NAFLD: a multisystem disease.J Hepatol. 2015 Apr;62(1 Suppl):S47-64. doi: 10.1016/j.jhep.2014.12.012. J Hepatol. 2015. PMID: 25920090 Review.
-
New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD).Protein Cell. 2018 Feb;9(2):164-177. doi: 10.1007/s13238-017-0436-0. Epub 2017 Jun 22. Protein Cell. 2018. PMID: 28643267 Free PMC article. Review.
-
Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD).Curr Pharm Des. 2020;26(10):1079-1092. doi: 10.2174/1381612826666200128094231. Curr Pharm Des. 2020. PMID: 32003662 Review.
-
Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.Nat Rev Endocrinol. 2018 Feb;14(2):99-114. doi: 10.1038/nrendo.2017.173. Epub 2017 Dec 29. Nat Rev Endocrinol. 2018. PMID: 29286050 Review.
Cited by
-
Associations of serum aminotransferase and the risk of all-cause and cause-specific mortality in Chinese type 2 diabetes: a community-based cohort study.BMJ Open. 2023 Jul 4;13(7):e068160. doi: 10.1136/bmjopen-2022-068160. BMJ Open. 2023. PMID: 37407041 Free PMC article.
-
Trends in intestinal aging: From underlying mechanisms to therapeutic strategies.Acta Pharm Sin B. 2025 Jul;15(7):3372-3403. doi: 10.1016/j.apsb.2025.05.011. Epub 2025 May 22. Acta Pharm Sin B. 2025. PMID: 40698139 Free PMC article. Review.
-
Can salivary and skin microbiome become a biodetector for aging-associated diseases? Current insights and future perspectives.Front Aging. 2024 Oct 17;5:1462569. doi: 10.3389/fragi.2024.1462569. eCollection 2024. Front Aging. 2024. PMID: 39484071 Free PMC article. Review.
-
Increased cell senescence in human metabolic disorders.J Clin Invest. 2023 Jun 15;133(12):e169922. doi: 10.1172/JCI169922. J Clin Invest. 2023. PMID: 37317964 Free PMC article. Review.
-
Awareness of Eating Disorders, Nutritional Knowledge, and Emotionally Driven Eating Among Polish Adolescents Aged 15-17-A Pilot Study.Nutrients. 2025 Jun 13;17(12):1994. doi: 10.3390/nu17121994. Nutrients. 2025. PMID: 40573104 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical